JLHL

Jupiter Life Line Hospitals Ltd.

NSE: JLHL

BSE: 543980

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Hospital

1,457.30+13.8 (+0.96%)

9 Jul, 10:59 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

95.0 / 100

Value Score

17.3 / 100

Price Momentum Score

73.7 / 100

QVM Score

72.7 / 100

Key Metrics

Market Cap

9600.17

P/E (TTM)

49.48

P/B

6.22

P/S (TTM)

6.40

EV/EBITDA

28.09

CAPE (5Y)

68.61

ROE (TTM)

13.38

ROCE (TTM)

13.18

ROA (TTM)

9.05

Avg 3Y ROE

17.24

Earnings 3Y CAGR

38.58

Sales 3Y CAGR

18.89

Sales 5Y CAGR

25.27

Debt/Equity

0.38

Consensus TP

1600.00

Strong Buy %

80.00

Promoter Holding

40.91

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Jupiter Life Line Hospitals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 73.7 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

73.7 / 100

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.38 as on 31 Mar 2026 and Debt to Equity increased marginally by 0.09 in the last 1 year

What is Debt to Equity?

Negative

Expensive and at same valuation levels as industry median P/E

PE TTM of 49.48 indicates that the stock is expensive on a standalone basis. Premium to industry median P/E is modest at 1.23%

What is P/E Ratio?

Median: 48.88

Value 49.48

-45.933066.63

Analysts have been downgrading forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has decreased by -0.71% in the last 3 months, indicating weak earnings momentum

What is Earnings upgrade (3M)?

Moderate ROE but declining trend

The company reported moderate ROE of 13.38% for 12-month ended 31 Mar 2026 but ROE declined by -194 bps from 1 year ago

What is ROE (FY)?

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of 0.26% for 12-month ended 31 Mar 2026 and the growth was 16.73 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.07%

What is Dividend yield?

Neutral

High operating margin but declining trend

The company reported strong operating margin of 17.04% for 12-month ended 31 Mar 2026 but operating margin declined by -195 bps from 1 year ago

What is Operating profit margin?

Moderate revenue growth and in line with median growth of industry

The company delivered moderate revenue growth of 18.88% for 12-month ended 31 Mar 2026 and the growth was 0.07 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 18.81

Value 18.88

-17.1910376.7

Company's earnings are of moderate quality

Earnings quality score of 55.1 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

55.1 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Jupiter Life Line Hospitals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Jupiter Life Line Hospitals Ltd. Shareholding Pattern

Quarterly breakdown of Jupiter Life Line Hospitals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Sep 2014	Sep 2015	Sep 2016	Sep 2017	Sep 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	49.39	14.51	14.51	15.46	15.97	15.97	15.97	15.97	15.97	40.91	40.91	40.91	40.91	40.91	40.91	40.91	40.91	40.91	40.91	40.91
Indian Promoter	49.39	14.51	14.51	15.46	15.97	15.97	15.97	15.97	15.97	40.91	40.91	40.91	40.91	40.91	40.91	40.91	40.91	40.91	40.91	40.91
Foreign Promoter	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	17.31	17.90	18.33	19.91	22.29	22.37	22.25	22.17	22.60	22.49	22.07
Mutual Funds / UTI	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	11.57	12.68	13.28	12.81	12.34	11.33	11.09	11.05	10.99	11.55	10.97
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.76	0.90	0.54	0.72	0.91	0.79	0.94	1.14	2.36	2.30	2.45
Govt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.62	3.96	4.17	6.06	8.84	10.04	10.04	9.77	9.06	8.48	8.48
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.36	0.34	0.34	0.32	0.21	0.21	0.19	0.21	0.20	0.17	0.17
Non-Institution	50.61	85.49	85.49	84.54	84.03	84.03	84.03	84.03	84.03	41.78	41.19	40.75	39.17	36.79	36.72	36.84	36.92	36.50	36.59	37.02
Bodies Corporate	0.00	38.77	38.77	38.34	38.90	38.90	38.90	38.90	38.90	5.76	5.71	5.66	5.73	5.71	5.70	5.71	5.74	5.74	5.82	6.07
Others (incl. Retail) No. of shareholders	50.61 0	46.72 0	46.72 0	46.20 0	45.13 0	45.13 0	45.13 0	45.13 0	45.13 0	36.02 54,679	35.48 39,251	35.09 34,997	33.44 35,668	31.08 33,937	31.02 33,764	31.13 33,790	31.18 34,022	30.76 34,181	30.77 33,444	30.95 32,814

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	SHI: Hospital	2.7%	11 / 18
2	Nifty Microcap 250	0.59%	41 / 250
3	Nifty Total Market	0.03%	452 / 749

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Jupiter Life Line Hospitals Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
BRINDHA RAGHAVAN	29 Aug 2024	sell	₹ 1,310.00	1.00 lac	₹ 13.10 cr
RAGHAVAN VADAPATRA SAYEE	29 Aug 2024	sell	₹ 1,310.00	1.00 lac	₹ 13.10 cr
THINK INDIA OPPORTUNITIES MASTER FUND LP	29 Aug 2024	buy	₹ 1,310.00	2.00 lac	₹ 26.20 cr

Corporate Actions

History of Jupiter Life Line Hospitals Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 1/share
Record date: 22nd May 2026Ex-date: 22nd May 2026
Announced on: 11th May 2026
Dividend₹ 1/share
Record date: 4th Jul 2025Ex-date: 4th Jul 2025
Announced on: 9th May 2025
Dividend₹ 1/share
Record date: 2nd Aug 2024Ex-date: 2nd Aug 2024
Announced on: 10th May 2024

Company Profile

Overview of Jupiter Life Line Hospitals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Jupiter Life Line Hospitals Limited is an India-based holding company. The Company is a multi-specialty tertiary and quaternary healthcare service provider in the Mumbai metropolitan area and western India. The Company has a total bed capacity of approximately 1,061 hospital beds across three hospit...

Key personnel

Dr. Rajendra Patankar

Chief Executive Officer of Pune Hospital

Mr. Harshad Purani

President - Administration, Head - Corporate Social Responsibility

Dr. Shilpa Tatake

Chief Executive Officer - Thane

Ms. Manisha Shah

Group Chief Human Resources Officer

Mrs. Suma Vinayak Upparatti

Compliance Officer, Company Secretary

Mr. Pradip Acharya

Group Head Industrial Health

Mr. Anand Apte

Chief Business and Strategy Officer

Mr. Sumit Goda

Corporate Head - Supply Chain and CPU

View all

Incorporated on

18 Nov 2002

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

3,002

IPO date

18 Sep 2023

Free Float

2,16,35,047

Website

https://www.jupiterhospital.com

Phone no.

+912262975555

Address

Eastern Express Highway, Service Rd, Next To Viviana Mall, THANE, 400601, India

Frequently Asked Questions

What is the current share price of Jupiter Life Line Hospitals Ltd.?

The current share price of Jupiter Life Line Hospitals Ltd. is ₹ 1,457.30 as of 9 Jul 2026.

What is the market capitalisation of Jupiter Life Line Hospitals Ltd.?

The market capitalisation of Jupiter Life Line Hospitals Ltd. stands at ₹ 9,600.17 Cr.

What is the PE ratio of Jupiter Life Line Hospitals Ltd.?

The Price-to-Earnings (PE) ratio of Jupiter Life Line Hospitals Ltd. is 49.48 as of the latest trailing twelve months data.

What is the ROE and ROCE of Jupiter Life Line Hospitals Ltd.?

Jupiter Life Line Hospitals Ltd. has a Return on Equity (ROE) of 13.38% and a Return on Capital Employed (ROCE) of 13.18% as per the latest financial reports.

What is the 52-week high and low of Jupiter Life Line Hospitals Ltd.?

The 52-week high of Jupiter Life Line Hospitals Ltd. is - and the 52-week low is -.

What is the dividend yield of Jupiter Life Line Hospitals Ltd.?

The dividend yield of Jupiter Life Line Hospitals Ltd. is 0.07% based on the current market price.

What is the FII and DII holding in Jupiter Life Line Hospitals Ltd.?

Foreign Institutional Investors (FII) hold 8.48%, Domestic Institutional Investors (DII) hold 13.42% and retail/public investors hold 30.95% of Jupiter Life Line Hospitals Ltd. shares.

What sector does Jupiter Life Line Hospitals Ltd. belong to?

Jupiter Life Line Hospitals Ltd. operates in the Healthcare sector. 100% of analysts have a Buy or Strong Buy rating on Jupiter Life Line Hospitals Ltd. with a consensus target price of ₹ 1,600.00, implying 9.27% upside from current levels.

What is the beta of Jupiter Life Line Hospitals Ltd.?

The beta of Jupiter Life Line Hospitals Ltd. is 0.29, indicating its price volatility relative to the broader market. Over the past 1 year, Jupiter Life Line Hospitals Ltd. has delivered an absolute return of -2.97%.

What is the RSI of Jupiter Life Line Hospitals Ltd.?

The 14-day Relative Strength Index (RSI) of Jupiter Life Line Hospitals Ltd. is 78.78, placing it in the overbought zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Jupiter Life Line Hospitals Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Jupiter Life Line Hospitals Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Company Profile

Stock Analysis

Corporate Actions

Holdings and Presence